Anders E. G. Lindgren

497 total citations
16 papers, 363 citations indexed

About

Anders E. G. Lindgren is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Anders E. G. Lindgren has authored 16 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Oncology. Recurrent topics in Anders E. G. Lindgren's work include PARP inhibition in cancer therapy (5 papers), Toxin Mechanisms and Immunotoxins (4 papers) and Chemical Synthesis and Analysis (2 papers). Anders E. G. Lindgren is often cited by papers focused on PARP inhibition in cancer therapy (5 papers), Toxin Mechanisms and Immunotoxins (4 papers) and Chemical Synthesis and Analysis (2 papers). Anders E. G. Lindgren collaborates with scholars based in Sweden, United States and Switzerland. Anders E. G. Lindgren's co-authors include Mikael Elofsson, H. Schüler, T. Ekblad, Fredrik Almqvist, Anna Linusson, T. Karlberg, A.G. Thorsell, David Andersson, Hanna Uvell and Christoffer Bengtsson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Anders E. G. Lindgren

15 papers receiving 356 citations

Peers

Countries citing papers authored by Anders E. G. Lindgren

Since Specialization

Citations

This map shows the geographic impact of Anders E. G. Lindgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders E. G. Lindgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders E. G. Lindgren more than expected).

Fields of papers citing papers by Anders E. G. Lindgren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders E. G. Lindgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders E. G. Lindgren. The network helps show where Anders E. G. Lindgren may publish in the future.

Co-authorship network of co-authors of Anders E. G. Lindgren

This figure shows the co-authorship network connecting the top 25 collaborators of Anders E. G. Lindgren. A scholar is included among the top collaborators of Anders E. G. Lindgren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders E. G. Lindgren. Anders E. G. Lindgren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Ring-fused 2-pyridones effective against multidrug-resistant Gram-positive pathogens and synergistic with standard-of-care antibiotics 2022 ·Proceedings of the National Academy of Sciences ·(unknown), Hasan Tükenmez, Pardeep Singh, Ana L. Flores‐Mireles, (unknown), Jerome S. Pinkner, Souvik Sarkar, (unknown), Anders E. G. Lindgren, Karen Dodson, Jörgen Johansson, Fredrik Almqvist, Michael G. Caparon, Scott J. Hultgren	11
2	THCz: Small molecules with antimicrobial activity that block cell wall lipid intermediates 2021 ·Proceedings of the National Academy of Sciences ·(unknown), (unknown), Kevin C. Ludwig, Anna Müller, Hanna Uvell, Fabian Grein, Anders E. G. Lindgren, Sandra Muschiol, Priyanka Nannapaneni, Anna Eriksson, Tanja Schneider, Staffan Normark, Birgitta Henriques‐Normark, Fredrik Almqvist, Peter Mellroth	15
3	Intramolecular Povarov Reactions for the Synthesis of Chromenopyridine Fused 2-Pyridone Polyheterocycles Binding to α-Synuclein and Amyloid-β Fibrils 2020 ·The Journal of Organic Chemistry ·(unknown), (unknown), Pardeep Singh, (unknown), Jörgen Ådén, Anna L. Gharibyan, (unknown), Anders E. G. Lindgren, Anders Olofsson, Fredrik Almqvist	18
4	The Bactericidal Fatty Acid Mimetic 2CCA-1 Selectively Targets Pneumococcal Extracellular Polyunsaturated Fatty Acid Metabolism 2020 ·mBio ·(unknown), Priyanka Nannapaneni, Olena Rzhepishevska, Anders E. G. Lindgren, (unknown), Staffan Normark, Fredrik Almqvist, Birgitta Henriques‐Normark, Peter Mellroth	7
5	Methyl sulfonamide substituents improve the pharmacokinetic properties of bicyclic 2-pyridone basedChlamydia trachomatisinhibitors 2019 ·MedChemComm ·(unknown), (unknown), Andrew G. Cairns, (unknown), Anders E. G. Lindgren, (unknown), Pardeep Singh, Katarina Vielfort, (unknown), James A. D. Good, Richard Svensson, Sven Bergström, Åsa Gylfe, Fredrik Almqvist	4
6	Identification of Poly(ADP-Ribose) Polymerase Macrodomain Inhibitors Using an AlphaScreen Protocol 2018 ·SLAS DISCOVERY ·T. Ekblad, Patricia Verheugd, Anders E. G. Lindgren, T. Nyman, Mikael Elofsson, H. Schüler	22
7	ChemInform Abstract: Total Synthesis of the Resveratrol Oligomers (.+‐.)‐Ampelopsin B and (.+‐.)‐ε‐Viniferin. 2016 ·ChemInform ·Anders E. G. Lindgren, (unknown), (unknown), Mikael Elofsson	1
8	Total Synthesis of the Resveratrol Oligomers (±)‐Ampelopsin B and (±)‐ϵ‐Viniferin 2015 ·European Journal of Organic Chemistry ·Anders E. G. Lindgren, Christopher T. Öberg, (unknown), Mikael Elofsson	36
9	Towards small molecule inhibitors of mono-ADP-ribosyltransferases 2015 ·European Journal of Medicinal Chemistry ·T. Ekblad, Anders E. G. Lindgren, David Andersson, Rémi Caraballo, A.G. Thorsell, T. Karlberg, (unknown), Anna Linusson, H. Schüler, Mikael Elofsson	43
10	N -Acylated Derivatives of Sulfamethoxazole and Sulfafurazole Inhibit Intracellular Growth of Chlamydia trachomatis 2014 ·Antimicrobial Agents and Chemotherapy ·(unknown), Hanna Uvell, (unknown), Anders E. G. Lindgren, (unknown), Mikael Elofsson, Åsa Gylfe	30
11	Modulation of Curli Assembly and Pellicle Biofilm Formation by Chemical and Protein Chaperones 2013 ·Chemistry & Biology ·(unknown), Christoffer Bengtsson, Margery L. Evans, Erik Chorell, Magnus Sellstedt, Anders E. G. Lindgren, David A. Hufnagel, (unknown), Peter M. Tessier, Pernilla Wittung‐Stafshede, Fredrik Almqvist, Matthew R. Chapman	62
12	Statistical Molecular Design: A Tool to Follow Up Hits from Small-Molecule Screening 2013 ·Methods in molecular biology ·Anders E. G. Lindgren, Andreas Larsson, Anna Linusson, Mikael Elofsson	0
13	Chemical Probes to Study ADP-Ribosylation: Synthesis and Biochemical Evaluation of Inhibitors of the Human ADP-Ribosyltransferase ARTD3/PARP3 2013 ·Journal of Medicinal Chemistry ·Anders E. G. Lindgren, T. Karlberg, T. Ekblad, (unknown), A.G. Thorsell, David Andersson, (unknown), (unknown), Johan Weigelt, Anna Linusson, H. Schüler, Mikael Elofsson	11
14	PARP Inhibitor with Selectivity Toward ADP-Ribosyltransferase ARTD3/PARP3 2013 ·ACS Chemical Biology ·Anders E. G. Lindgren, T. Karlberg, A.G. Thorsell, (unknown), (unknown), T. Ekblad, David Andersson, A.F. Pinto, Johan Weigelt, Michael O. Hottiger, Anna Linusson, Mikael Elofsson, H. Schüler	49
15	Design, synthesis and evaluation of triazole functionalized ring-fused 2-pyridones as antibacterial agents 2012 ·European Journal of Medicinal Chemistry ·Christoffer Bengtsson, Anders E. G. Lindgren, Hanna Uvell, Fredrik Almqvist	19
16	Discovery of Ligands for ADP-Ribosyltransferases via Docking-Based Virtual Screening 2012 ·Journal of Medicinal Chemistry ·David Andersson, T. Karlberg, T. Ekblad, Anders E. G. Lindgren, A.G. Thorsell, (unknown), Urszula Uciechowska, (unknown), Pernilla Wittung‐Stafshede, Johan Weigelt, Mikael Elofsson, H. Schüler, Anna Linusson	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact